drugset / Trial / NCT02532309
A Study to Evaluate the Efficacy and Safety of Rosuvastatin in the Treatment of the Carotid Atherosclerotic Plaques
Phase 4
Unknown
308 enrolled
Wei Liu
AstraZeneca · collabBeijing Clinstech-med consulting Co., Ltd · collabUniversity of Washington · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
This is a 2-year, open-label, randomized study to evaluate the efficacy of Rosuvastatin dosing adjustment by LDL-C level compared to that of 5mg maintenance dose in chinese patients with Carotid Atherosclerosis.
Timeline
- Start
- 2015-04
- Primary completion
- 2018-04
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Rosuvastatin | Small molecule | 5 mg | — |
| Subject | Rosuvastatin | Small molecule | 10 mg | — |
| Subject | Rosuvastatin | Small molecule | 20 mg | — |